Jiangsu Hengrui Pharmaceuticals Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000014W7
CNY
61.25
0.13 (0.21%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

18.04 M

Shareholding (Jun 2025)

FII

0.00%

Held by 1 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 4.19% and Operating profit at 5.55% over the last 5 years

 
2

The company declared negative results in Mar'25 after positive results in Dec'24

3

With ROE of 12.29%, it has a very expensive valuation with a 7.59 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 443,816 Million (Large Cap)

stock-summary
P/E

62.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.29%

stock-summary
Debt Equity

-0.61

stock-summary
Return on Equity

12.29%

stock-summary
Price to Book

7.59

Revenue and Profits:
Net Sales:
8,492 Million
(Quarterly Results - Jun 2025)
Net Profit:
2,578 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-14.91%
0%
-14.91%
6 Months
11.61%
0%
11.61%
1 Year
23.41%
0%
23.41%
2 Years
31.49%
0%
31.49%
3 Years
51.23%
0%
51.23%
4 Years
24.49%
0%
24.49%
5 Years
-18.32%
0%
-18.32%

Jiangsu Hengrui Pharmaceuticals Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
4.19%
EBIT Growth (5y)
5.55%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.57
Tax Ratio
12.26%
Dividend Payout Ratio
18.49%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
99,562.58%
ROE (avg)
135,472.87%
Valuation key factors
Factor
Value
P/E Ratio
62
Industry P/E
Price to Book Value
7.59
EV to EBIT
53.84
EV to EBITDA
48.08
EV to Capital Employed
17.95
EV to Sales
13.66
PEG Ratio
1.92
Dividend Yield
0.29%
ROCE (Latest)
33.33%
ROE (Latest)
12.29%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 18.84% vs -7.32% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 37.40% vs 9.05% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8,491.70",
          "val2": "7,145.60",
          "chgp": "18.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,854.70",
          "val2": "2,227.40",
          "chgp": "28.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "10.90",
          "chgp": "-93.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "124.40",
          "val2": "-13.10",
          "chgp": "1,049.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,578.20",
          "val2": "1,876.40",
          "chgp": "37.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "309.00%",
          "val2": "279.40%",
          "chgp": "2.96%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 22.68% vs 7.19% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 48.14% vs 12.13% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "27,726.70",
          "val2": "22,600.50",
          "chgp": "22.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7,271.20",
          "val2": "4,901.20",
          "chgp": "48.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.50",
          "val2": "6.70",
          "chgp": "-2.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "108.60",
          "val2": "-128.30",
          "chgp": "184.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6,337.00",
          "val2": "4,277.80",
          "chgp": "48.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "230.80%",
          "val2": "181.70%",
          "chgp": "4.91%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
8,491.70
7,145.60
18.84%
Operating Profit (PBDIT) excl Other Income
2,854.70
2,227.40
28.16%
Interest
0.70
10.90
-93.58%
Exceptional Items
124.40
-13.10
1,049.62%
Consolidate Net Profit
2,578.20
1,876.40
37.40%
Operating Profit Margin (Excl OI)
309.00%
279.40%
2.96%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 18.84% vs -7.32% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 37.40% vs 9.05% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
27,726.70
22,600.50
22.68%
Operating Profit (PBDIT) excl Other Income
7,271.20
4,901.20
48.36%
Interest
6.50
6.70
-2.99%
Exceptional Items
108.60
-128.30
184.65%
Consolidate Net Profit
6,337.00
4,277.80
48.14%
Operating Profit Margin (Excl OI)
230.80%
181.70%
4.91%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 22.68% vs 7.19% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 48.14% vs 12.13% in Dec 2023

stock-summaryCompany CV
About Jiangsu Hengrui Pharmaceuticals Co., Ltd. stock-summary
stock-summary
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available